ht_impella_080822_mn-1
Feature | Dave Fornell

October 1, 2010 – The most recent clinical data from USpella, a U.S. multicenter, observational registry of patients who received percutaneous cardiac support from the Impella 2.5 device, was released at TCT 2010 last week.

Home October 01, 2010
Home
News

October 1, 2010 – The U.S. Food and Drug Adminstration (FDA) Center for Drug Evaluation and Research (CDER) has awarded two contracts to support the agency’s review of cardiac safety data. Both contracts were given to Mortara Instrument.

Home October 01, 2010
Home
News

October 1, 2010 – An early-warning system for detecting coronary occlusion has received the CE mark for commercial sale in Europe. The AngelMed Guardian System, by Angel Medical Systems, is designed to detect coronary occlusion from thrombotic events, such as plaque ruptures, and alert the patient, often before any symptoms occur.

Home October 01, 2010
Home
Technology

September 30, 2010 – New angiography navigation tools for structural heart cases were shown by GE Healthcare during last week's Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium.

Home September 30, 2010
Home
News

September 30, 2010 – A specialized partner program was recently launched to enable select top healthcare institutions to provide advanced training in hemodynamic support and complex patient management.

Home September 30, 2010
Home
News

September 30, 2010 – The U.S. Food and Drug Administration (FDA) has cleared a software interface and image segmentation system that can help simulate and evaluate surgical treatment options.

Home September 30, 2010
Home
Technology

September 29, 2010 – A new portable, arm-held ultrasound system can provide fast, easy and reliable diagnosis even in critical emergency situations. The MyLabOne, by Biosound Esaote, is lightweight and features a 12-inch, color, touch-screen display.

Home September 29, 2010
Home
News

September 29, 2010 - Preclinical data of a therapy designed to treat drug-resistant hypertension was presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium in Washington, D.C.

Home September 29, 2010
Home
News

September 29, 2010 – Physicians from the Cedars-Sinai Heart Institute will lead a clinical trial evaluating transcatheter aortic valve implantation (TAVI) for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery. The trial will study St. Jude Medical’s transcatheter aortic valve.

Home September 29, 2010
Home
News

September 29, 2010 – Results from a trial studying the effects of a drug-eluting balloon (DEB) on peripheral artery disease (PAD) were released at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium.

Home September 29, 2010
Home
sapien-valve
Feature | Dave Fornell

Transcatheter valve therapies were among the hottest topics at the 2010 Transcatheter Cardiovascular Therapeutics (TCT) symposium and the key presentation was the very positive first release of data from the U.S. PARTNER trial. The trial results are widely expected to open the door to a major transition away from surgical to transcatheter aortic valve repair in the coming years.

Home September 29, 2010
Home
News

September 29, 2010 – A prospective study found that an implantable cardiac monitor detected arrhythmias in patients who had suffered a heart attack.

Home September 29, 2010
Home
Technology

September 29, 2010 – An agreement was reached between AccessClosure and Benrikal Services for distributing vascular closure devices in the United States. AccessClosure will be the exclusive distributor for the Bengal Radial Compression Band, which helps close the radial artery after a cardiovascular procedure.

Home September 29, 2010
Home
News

September 28, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium featured a live case broadcast of a physician implanting a new device to treat refractory angina.

Home September 28, 2010
Home
News

September 28, 2010 – A new multinational trial will examine the effectiveness of embolic protection mesh stents in STEMI (ST-elelvated myocardial infarction) patients. The MASTER trial will compare the MGuard coronary stent, made by InspireMD, with standard care. The MGuard stent is covered in a polymer mesh to prevent emboli from escaping when the stent is expanded.

Home September 28, 2010
Home
Subscribe Now